Keytruda For Prostate Cancer | Ask a Prostate Expert, Mark Scholz, MD

New FDA Approval: Darolutamide for Hormone-Sensitive Disease | Mark Scholz, MD | PCRIПодробнее

New FDA Approval: Darolutamide for Hormone-Sensitive Disease | Mark Scholz, MD | PCRI

Proton Therapy, IMRT, and SBRT | Mark Scholz, MD | PCRIПодробнее

Proton Therapy, IMRT, and SBRT | Mark Scholz, MD | PCRI

Orgovyx, Nubeqa, & Early Taxotere | 2021 Treatments In Review | Mark Scholz, MDПодробнее

Orgovyx, Nubeqa, & Early Taxotere | 2021 Treatments In Review | Mark Scholz, MD

Are Radiation Patients Radioactive? | Mark Scholz, MD | PCRIПодробнее

Are Radiation Patients Radioactive? | Mark Scholz, MD | PCRI

Is Firmagon Safer or More Tolerable Than Lupron? | Mark Scholz, MD | PCRIПодробнее

Is Firmagon Safer or More Tolerable Than Lupron? | Mark Scholz, MD | PCRI

Immunotherapy in 2022: Provenge, Keytruda, Car-T, and Leukine for Prostate Cancer | Mark Scholz, MDПодробнее

Immunotherapy in 2022: Provenge, Keytruda, Car-T, and Leukine for Prostate Cancer | Mark Scholz, MD

Immunotherapy In 2021, Mark Scholz, MD, Prostate Cancer Support Association of New MexicoПодробнее

Immunotherapy In 2021, Mark Scholz, MD, Prostate Cancer Support Association of New Mexico

Does Hormone Therapy Cause Cognitive Decline? | Answering YouTube Comments #62 | Mark Scholz, MDПодробнее

Does Hormone Therapy Cause Cognitive Decline? | Answering YouTube Comments #62 | Mark Scholz, MD

BRCA, MSI, and Useful Genetic Tests in Prostate Cancer | Answering YouTube Comments #45 | PCRIПодробнее

BRCA, MSI, and Useful Genetic Tests in Prostate Cancer | Answering YouTube Comments #45 | PCRI

Provenge, Keytruda, & Protecting Nerve Bundles From Radiation | Answering YouTube Comments #42Подробнее

Provenge, Keytruda, & Protecting Nerve Bundles From Radiation | Answering YouTube Comments #42

Postponing Hormone Resistance and Perineural Invasion | Answering YouTube Comments #41 | Dr. ScholzПодробнее

Postponing Hormone Resistance and Perineural Invasion | Answering YouTube Comments #41 | Dr. Scholz

Small Cell Tumors and Prostate Cancer | Answering YouTube Comments #29 | Mark Scholz, MDПодробнее

Small Cell Tumors and Prostate Cancer | Answering YouTube Comments #29 | Mark Scholz, MD

Focal Radiation, Antibiotics, & ED after Hormone Therapy, Ask a Prostate Expert, Mark Scholz, MD #12Подробнее

Focal Radiation, Antibiotics, & ED after Hormone Therapy, Ask a Prostate Expert, Mark Scholz, MD #12

3 Future Prostate Cancer Treatment Advancements | Mark Scholz, MD & Mark Moyad, MD | 2021 PCRIПодробнее

3 Future Prostate Cancer Treatment Advancements | Mark Scholz, MD & Mark Moyad, MD | 2021 PCRI

2021: PSMA and Prostate Imaging | Dr. Thomas Hope | 2021 Moyad + Scholz Mid-Year Update | PCRIПодробнее

2021: PSMA and Prostate Imaging | Dr. Thomas Hope | 2021 Moyad + Scholz Mid-Year Update | PCRI

Xofigo | How It Works, Side Effects, and More | Ask a Prostate Expert, Mark Scholz, MD | PCRIПодробнее

Xofigo | How It Works, Side Effects, and More | Ask a Prostate Expert, Mark Scholz, MD | PCRI

What Is M0 Prostate Cancer and How Is It Identified? | Ask a Prostate Expert, Mark Scholz, MDПодробнее

What Is M0 Prostate Cancer and How Is It Identified? | Ask a Prostate Expert, Mark Scholz, MD

PSMA/PET Scans: FDA Approved | Ask A Prostate Expert, Mark Scholz, MDПодробнее

PSMA/PET Scans: FDA Approved | Ask A Prostate Expert, Mark Scholz, MD

Immune Health and Prostate Cancer | Ask a Prostate Expert, Mark Scholz, MDПодробнее

Immune Health and Prostate Cancer | Ask a Prostate Expert, Mark Scholz, MD

Immune Therapy: Future Game Changers In Prostate Cancer | Ask a Prostate Expert, Mark Scholz, MDПодробнее

Immune Therapy: Future Game Changers In Prostate Cancer | Ask a Prostate Expert, Mark Scholz, MD

События